Stomach cancer classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
|- | |- | ||
|- | |- | ||
|'''1. Negative for dysplasia''' | |||
1.0 Normal | 1.0 Normal | ||
Line 22: | Line 21: | ||
1.2.2 IM Incomplete type | 1.2.2 IM Incomplete type | ||
|- | |- | ||
|'''2. Indefinite for dysplasia''' | |'''2. Indefinite for dysplasia''' | ||
Line 48: | Line 42: | ||
|'''5. Invasive adenocarcinoma''' | |'''5. Invasive adenocarcinoma''' | ||
|} | |} | ||
==References== | ==References== |
Revision as of 14:50, 1 November 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Stomach cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Stomach cancer classification On the Web |
American Roentgen Ray Society Images of Stomach cancer classification |
Risk calculators and risk factors for Stomach cancer classification |
Overview
Classification
Padova classification |
1. Negative for dysplasia
1.0 Normal 1.1 Reactive foveolar hyperplasia 1.2 Intestinal metaplasia (IM) 1.2.1 IM Complete type 1.2.2 IM Incomplete type |
2. Indefinite for dysplasia
2.1 Foveolar hyperproliferation 2.2 Hyperproliferative IM |
3. Non-invasive neoplasia (flat or elevated [synonym adenoma])
3.1 Low-grade 3.2 High-grade 3.2.1 Including suspicious for carcinoma without invasion (intreglandular) 3.2.2 Including carcinoma without invasion (intraglandular) |
4. Suspicious for invasive carcinoma |
5. Invasive adenocarcinoma |